1.Time in Therapeutic Range and Percentage of International Normalized Ratio in the Therapeutic Range as a Measure of Quality of Anticoagulation Control in Patients With Atrial Fibrillation

Chan, PH, Li, WH, Ha     More...

Chan, PH, Li, WH, Hai, JJ, Chan, EW, Wong, ICK, Tse, HF, Lip, GYH, Siu, CW     Less

CANADIAN JOURNAL OF CARDIOLOGY[0828-282X], Published 2016, Volume 32, Issue 10, Pages 1247.e23-1247.e28

收錄情况： WOS SCOPUS

WOS核心合集引用: 14  2023影響因子:  5.8  发表年影響因子:  4.403 

2.Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA₂DS₂-VASc and Time in Therapeutic Range

Chan, PH, Huang, D,     More...

Chan, PH, Huang, D, Lau, CP, Chan, EW, Wong, ICK, Lip, GYH, Tse, HF, Siu, CW     Less

CANADIAN JOURNAL OF CARDIOLOGY[0828-282X], Published 2016, Volume 32, Issue 10, Pages 1247.e15-1247.e21

收錄情况： WOS SCOPUS

WOS核心合集引用: 16  2023影響因子:  5.8  发表年影響因子:  4.403